{"id":"https://openalex.org/W4379983442","doi":"https://doi.org/10.1158/1538-7445.am2023-2658","title":"Abstract 2658: ZW251, a novel glypican-3-targeting antibody drug conjugate bearing a topoisomerase 1 inhibitor payload","display_name":"Abstract 2658: ZW251, a novel glypican-3-targeting antibody drug conjugate bearing a topoisomerase 1 inhibitor payload","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4379983442","doi":"https://doi.org/10.1158/1538-7445.am2023-2658"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-2658","doi":"https://doi.org/10.1158/1538-7445.am2023-2658","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2023-2658","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062606621","display_name":"Laurence Madera","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Laurence Madera","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056200860","display_name":"Andrea Hern\u00e1ndez Rojas","orcid":"https://orcid.org/0000-0002-0278-9434","observed_orcids":["https://orcid.org/0000-0002-0278-9434"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Andrea Hern\u00e1ndez Rojas","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020780697","display_name":"Raffaele Colombo","orcid":"https://orcid.org/0000-0001-5709-4704","observed_orcids":["https://orcid.org/0000-0001-5709-4704"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Raffaele Colombo","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Alex Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Alex Wu","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047067501","display_name":"Chayne L. Piscitelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Chayne L. Piscitelli","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072941072","display_name":"Dunja Urosev","orcid":"https://orcid.org/0009-0002-6679-028X","observed_orcids":["https://orcid.org/0009-0002-6679-028X"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Dunja Urosev","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092122798","display_name":"Allysha Bissessur","orcid":"https://orcid.org/0009-0007-7597-3500","observed_orcids":["https://orcid.org/0009-0007-7597-3500"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Allysha Bissessur","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051168917","display_name":"Chi Wing Cheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Chi Wing Cheng","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063229159","display_name":"Renee Duan","orcid":"https://orcid.org/0009-0004-5966-8010","observed_orcids":["https://orcid.org/0009-0004-5966-8010"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Renee Duan","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020240630","display_name":"Catrina Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Catrina Kim","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112418484","display_name":"Kevin Yin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Kevin Yin","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065872876","display_name":"Vincent Fung","orcid":"https://orcid.org/0009-0003-8513-0591","observed_orcids":["https://orcid.org/0009-0003-8513-0591"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Vincent Fung","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033698777","display_name":"Kaylee J. Wu","orcid":"https://orcid.org/0009-0009-6827-5960","observed_orcids":["https://orcid.org/0009-0009-6827-5960"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Kaylee Wu","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Winnie Cheung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Winnie Cheung","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042018789","display_name":"D.A. Alonzo","orcid":"https://orcid.org/0000-0002-3586-3485","observed_orcids":["https://orcid.org/0000-0002-3586-3485"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Diego A. Alonzo","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103028352","display_name":"Mark E. Petersen","orcid":"https://orcid.org/0000-0003-2629-1363","observed_orcids":["https://orcid.org/0000-0003-2629-1363"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Mark E. Petersen","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069995028","display_name":"Stuart D. Barnscher","orcid":"https://orcid.org/0009-0000-2386-5240","observed_orcids":["https://orcid.org/0009-0000-2386-5240"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Stuart D. Barnscher","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069149184","display_name":"Jamie R. Rich","orcid":"https://orcid.org/0009-0008-0926-1318","observed_orcids":["https://orcid.org/0009-0008-0926-1318"]},"institutions":[{"id":"https://openalex.org/I4210098574","display_name":"Zymeworks (Canada)","ror":"https://ror.org/016aygb24","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210098574"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jamie R. Rich","raw_affiliation_strings":["1Zymeworks Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Zymeworks Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210098574"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210098574"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"7_Supplement","first_page":"2658","last_page":"2658"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.4293999969959259,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.4293999969959259,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.3366999924182892,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.10750000178813934,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9129999876022339},{"id":"https://openalex.org/keywords/glypican-3","display_name":"glypican-3","score":0.9940000176429749},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9020000100135803},{"id":"https://openalex.org/keywords/topoisomerase-i-inhibitor","display_name":"topoisomerase I inhibitor","score":0.9750000238418579},{"id":"https://openalex.org/keywords/camptothecin-derivatives","display_name":"camptothecin derivatives","score":0.843999981880188},{"id":"https://openalex.org/keywords/maleimide-linker","display_name":"maleimide linker","score":0.671999990940094},{"id":"https://openalex.org/keywords/antibody-internalization","display_name":"antibody internalization","score":0.7760000228881836},{"id":"https://openalex.org/keywords/bystander-killing","display_name":"bystander killing","score":0.8399999737739563},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.593999981880188},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.6790000200271606},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.7170000076293945}],"concepts":[{"id":"https://openalex.org/C2779742787","wikidata":"https://www.wikidata.org/wiki/Q18026064","display_name":"Glypican 3","level":3,"score":0.6294105052947998},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6261672377586365},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.6135258078575134},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5526547431945801},{"id":"https://openalex.org/C2778556491","wikidata":"https://www.wikidata.org/wiki/Q1660173","display_name":"Immunoconjugate","level":4,"score":0.5246827006340027},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.5170283913612366},{"id":"https://openalex.org/C139770010","wikidata":"https://www.wikidata.org/wiki/Q1339807","display_name":"Internalization","level":3,"score":0.477223664522171},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.45958414673805237},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.43408453464508057},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.42970627546310425},{"id":"https://openalex.org/C2779682216","wikidata":"https://www.wikidata.org/wiki/Q419964","display_name":"Camptothecin","level":2,"score":0.42066189646720886},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.4125380218029022},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4098323881626129},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.38578563928604126},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3734089136123657},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.31448525190353394},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.18610602617263794},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18177112936973572},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.174721360206604},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-2658","doi":"https://doi.org/10.1158/1538-7445.am2023-2658","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2023-2658","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7122362891","https://openalex.org/W4393076181","https://openalex.org/W7148886374","https://openalex.org/W2794923942","https://openalex.org/W7148649542","https://openalex.org/W7148669395","https://openalex.org/W4409626158","https://openalex.org/W4380082910","https://openalex.org/W7164916864","https://openalex.org/W2077593040"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Glypican-3":[2],"(GPC3)":[3],"is":[4,23],"a":[5,33,39,47,51,109,138,181,196,244,279,298,307,320,373,380],"cell-surface":[6],"oncofetal":[7],"glycoprotein":[8],"frequently":[9],"expressed":[10],"in":[11,18,116,137,168,180,232,243,251,268,283,292],"hepatocellular":[12],"carcinoma":[13],"(HCC)":[14],"with":[15,270],"minimal":[16],"presence":[17],"normal":[19],"adult":[20],"tissues.":[21],"ZW251":[22,79,113,164,177,203,228,237,257,276,290,318],"an":[24],"antibody-drug":[25],"conjugate":[26,378],"(ADC)":[27],"targeting":[28],"human":[29,84,172,212],"GPC3,":[30,216],"composed":[31],"of":[32,72,77,100,140,162,176,184,198,227,246,262,289,297,301,309,317,388],"humanized":[34],"IgG1":[35],"antibody":[36,114,165,204,229,277,376],"conjugated":[37],"to":[38,68,83,151,210,220],"novel":[40,321,374],"camptothecin-based":[41],"topoisomerase":[42,381],"1":[43,382,399],"inhibitor,":[44],"ZD06519,":[45],"via":[46],"maleimide":[48],"anchor":[49],"and":[50,61,74,85,95,103,133,189,213,217,240,303,401],"glycyl":[52,53],"phenylalanyl":[54],"glycine":[55],"(GGFG)-aminomethyl":[56],"(AM)":[57],"cleavable":[58],"linker.":[59],"Materials":[60],"Methods:":[62],"Extensive":[63],"functional":[64],"characterization":[65],"was":[66,89,106,121,135,166,178,230],"performed":[67,150],"assess":[69,152],"the":[70,78,163,315,389],"mechanism":[71],"action":[73],"therapeutic":[75,322],"potential":[76,316],"ADC.":[80],"Antibody":[81],"binding":[82,102,208,219],"cynomolgus":[86,214],"monkey":[87,215],"GPC3":[88,199,263,271],"assessed":[90,122,136,167],"by":[91,123,156],"surface":[92],"plasmon":[93],"resonance":[94],"flow":[96,124],"cytometry.":[97,125],"A":[98,286],"screen":[99],"off-target":[101],"target":[104],"specificity":[105],"conducted":[107],"using":[108],"membrane":[110],"proteome":[111],"array.":[112],"internalization":[115,226],"GPC3-expressing":[117,233],"tumor":[118,131,294],"cell":[119,142,145,154,185,223,235],"lines":[120],"In":[126],"vitro":[127],"ADC":[128],"cytotoxicity":[129,242],"against":[130,324],"monolayers":[132],"spheroids":[134],"panel":[139,183,245,300],"HCC":[141,234,247],"lines.":[143,224,236],"Tumor":[144],"co-culture":[146,269],"assays":[147],"were":[148],"also":[149],"bystander-mediated":[153,260],"killing":[155,261],"ZW251.":[157],"The":[158,202,275],"pharmacokinetic":[159],"(PK)":[160],"profile":[161,282],"Tg32":[169,284],"mice":[170],"expressing":[171],"FcRn.":[173],"Anti-tumor":[174],"activity":[175],"investigated":[179],"large":[182,299],"line-derived":[186],"xenograft":[187,191],"(CDX)":[188],"patient-derived":[190],"(PDX)":[192],"mouse":[193],"models":[194,305],"representing":[195,306],"range":[197,308],"expression.":[200],"Results:":[201],"backbone":[205],"demonstrated":[206,278],"nanomolar":[207],"affinity":[209],"both":[211],"strong":[218],"target-expressing":[221],"cancer":[222,265,273],"Rapid":[225],"observed":[231],"exhibited":[238],"potent":[239],"target-specific":[241],"cells":[248,266],"cultured":[249],"either":[250],"monolayer":[252],"or":[253],"as":[254,319],"3D":[255],"spheroids.":[256],"showed":[258],"effective":[259],"negative":[264],"when":[267],"positive":[272],"cells.":[274],"favorable":[280],"PK":[281],"mice.":[285],"single":[287],"administration":[288],"resulted":[291],"robust":[293],"growth":[295],"inhibition":[296],"CDX":[302],"PDX":[304],"GPC3-expression.":[310],"Overall,":[311],"these":[312],"results":[313],"support":[314],"agent":[323],"GPC3-bearing":[325],"cancers.":[326],"Citation":[327],"Format:":[328],"Laurence":[329],"Madera,":[330],"Andrea":[331],"Hern\u00e1ndez":[332],"Rojas,":[333],"Raffaele":[334],"Colombo,":[335],"Alex":[336],"Wu,":[337,357],"Chayne":[338],"L.":[339],"Piscitelli,":[340],"Dunja":[341],"Urosev,":[342],"Allysha":[343],"Bissessur,":[344],"Chi":[345],"Wing":[346],"Cheng,":[347],"Renee":[348],"Duan,":[349],"Catrina":[350],"Kim,":[351],"Kevin":[352],"Yin,":[353],"Vincent":[354],"Fung,":[355],"Kaylee":[356],"Winnie":[358],"Cheung,":[359],"Diego":[360],"A.":[361],"Alonzo,":[362],"Mark":[363],"E.":[364],"Petersen,":[365],"Stuart":[366],"D.":[367],"Barnscher,":[368],"Jamie":[369],"R.":[370],"Rich.":[371],"ZW251,":[372],"glypican-3-targeting":[375],"drug":[377],"bearing":[379],"inhibitor":[383],"payload":[384],"[abstract].":[385],"In:":[386],"Proceedings":[387],"American":[390],"Association":[391],"for":[392],"Cancer":[393,412],"Research":[394],"Annual":[395],"Meeting":[396],"2023;":[397],"Part":[398],"(Regular":[400],"Invited":[402],"Abstracts);":[403],"2023":[404],"Apr":[405],"14-19;":[406],"Orlando,":[407],"FL.":[408],"Philadelphia":[409],"(PA):":[410],"AACR;":[411],"Res":[413],"2023;83(7_Suppl):Abstract":[414],"nr":[415],"2658.":[416]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2023-06-10T00:00:00"}